Molecular Human Reproduction, Vol. 8, No. 5, 447-455,
May 2002
© 2002 European Society of Human Reproduction and Embryology
Uterine physiology |
Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells
Department of Obstetrics and Gynecology, Yale University, School of Medicine, 333 Cedar St FMB 202, New Haven, CT 06520, USA
The process of apoptosis is responsible for normal cellular turnover in numerous tissues throughout the body. The endometrial layer of the uterus shows steroid-dependent cyclic changes in structure and function. After a proliferative and secretory phase, steroid support is withdrawn and the uterine epithelium is shed. We hypothesize that the apoptosis observed in endometrial cells following hormonal withdrawal is mediated by the Fas/Fas ligand (FasL) system. Normal endometrial cells and endometrial cancer cells were cultured in the presence of estrogen and progesterone. In order to mimic physiological hormonal changes, estrogen and progesterone were removed from the media. Apoptosis was determined by 3-[4,5-dimethylthiazol-2-yl]-2,5-dephenyl tetrazolium bromide (MTT) assay and propidium iodide staining, while Fas and FasL expression were evaluated by Western blot analysis. The endometrial cells expressed Fas and low levels of FasL. Withdrawal of estrogen and/or progesterone from the culture induced apoptosis causing an ~50% decrease in cell viability. This coincided with increased Fas and FasL expression. Treatment of the cells with anti-FasL antibody prevented cell death following hormonal withdrawal. Estrogen and progesterone therefore represent survival factors which hamper cell death by impeding the expression of apoptotic factors. Our results indicate that Fas-mediated apoptosis is important for endometrial cycling and suggest that dysregulation of the Fas/FasL interactions may have an important role in the development of endometrial cancer.
apoptosis/endometrium/estrogen/Fas/progesterone
1 To whom correspondence should be addressed. E-mail: gil.mor{at}yale.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Chaudhry and E. Asselin Resistance to chemotherapy and hormone therapy in endometrial cancer Endocr. Relat. Cancer, June 1, 2009; 16(2): 363 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shao, M. Nutu, B. Weijdegard, E. Egecioglu, J. Fernandez-Rodriguez, L. Karlsson-Lindahl, K. Gemzell-Danielsson, C. Bergh, and H. Billig Clomiphene Citrate Causes Aberrant Tubal Apoptosis and Estrogen Receptor Activation in Rat Fallopian Tube: Implications for Tubal Ectopic Pregnancy Biol Reprod, June 1, 2009; 80(6): 1262 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zimmermann, W. Ackermann, and H. Alexander Epithelial Human Chorionic Gonadotropin Is Expressed and Produced in Human Secretory Endometrium During the Normal Menstrual Cycle Biol Reprod, May 1, 2009; 80(5): 1053 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Jaita, M. Candolfi, V. Zaldivar, S. Zarate, L. Ferrari, D. Pisera, M. G. Castro, and A. Seilicovich Estrogens Up-Regulate the Fas/FasL Apoptotic Pathway in Lactotropes Endocrinology, November 1, 2005; 146(11): 4737 - 4744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nishida, K. Nasu, T. Ueda, J. Fukuda, N. Takai, and I. Miyakawa Endometriotic cells are resistant to interferon-{gamma}-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis Mol. Hum. Reprod., January 1, 2005; 11(1): 29 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Krikun, G. Mor, A. Alvero, S. Guller, F. Schatz, E. Sapi, M. Rahman, R. Caze, M. Qumsiyeh, and C. J. Lockwood A Novel Immortalized Human Endometrial Stromal Cell Line with Normal Progestational Response Endocrinology, May 1, 2004; 145(5): 2291 - 2296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Harada, A. Kaponis, T. Iwabe, F. Taniguchi, G. Makrydimas, N. Sofikitis, M. Paschopoulos, E. Paraskevaidis, and N. Terakawa Apoptosis in human endometrium and endometriosis Hum. Reprod. Update, January 1, 2004; 10(1): 29 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Straszewski-Chavez, V. M. Abrahams, E. F. Funai, and G. Mor X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis Mol. Hum. Reprod., January 1, 2004; 10(1): 33 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Abrahams, S. L. Straszewski, M. Kamsteeg, B. Hanczaruk, P. E. Schwartz, T. J. Rutherford, and G. Mor Epithelial Ovarian Cancer Cells Secrete Functional Fas Ligand Cancer Res., September 1, 2003; 63(17): 5573 - 5581. [Abstract] [Full Text] [PDF]
|
|